Home' Australian Pharmacist : Australian Pharmacist February 2015 Contents Australian Pharmacist February 2015 I ©Pharmaceutical Society of Australia Ltd. 77
Denmark's pharmaceutical market will decline in value from $3.5 billion
in 2013 to $3 billion by 2020, with price-cap agreements and high tax
rates on pharmaceutical products two of the largest barriers to growth,
according to research and consulting firm GlobalData.
The company's report, CountryFocus:
Healthcare, regulatory and
reimbursement landscape -- Denmark,
states that price-cap agreements
between the Danish Ministry of
Health and the Danish Association
of Pharmaceutical Industry have
existed since 2008 and continue to
limit pharmaceutical market growth
as the government aims to keep drug
This is further exacerbated by the
25% value added tax on pharmaceutical
products, which is high compared with
other EU countries, restricted sales of
over-the-counter medicines and a costly
However, Joshua Owide, GlobalData's
Director of Healthcare Industry
Dynamics, said there were favourable
conditions which would be sustained
by increasing demand for medicine and
higher healthcare expenditure, as well
as government healthcare reforms.
'Denmark's corporate taxes are to be
gradually reduced to 22% by 2016
and the country does not levy capital
duty, share transfer duty or wealth
taxes. This benign tax environment
could encourage pharmaceutical
companies to set up business in
Denmark. Furthermore, the registration
of a pharmaceutical product under the
national procedure in Denmark takes
an average of 6--12 months. This is
less than the average time taken by
regulatory authorities in the US and
EU, which is currently 322 days and
366 days, respectively,' he said.
Mr Owide said that pharmaceuticals
are one of Denmark's largest export
goods. In 2013, the country exported
$12.1 billion worth of pharmaceutical
products, accounting for almost 11.4%
of Danish exports.
Danish pharma market decline
Make the dream of becoming a doctor a reality, earn
your MD at Oceania University of Medicine.
Attractive fee structure for our Graduate Entry Program.
Over 150 students currently enrolled and over 50
graduates in Australia, New Zealand, Samoa and USA.
Home-based Pre-Clinical Study under top international
medical school scholars, using world leading Pre-Clinical,
24/7 online delivery techniques.
Clinical Rotations can be performed locally, Interstate or
Receive personalised attention from an Academic Advisor.
OUM Graduates are eligible to sit the AMC exam or NZREX.
OCEANIA UNIVERSITY OF MEDICINE
INTERNATIONALLY ACCREDITED For information visit www.oceaniamed.org or 1300 665 343
Applications now open for courses starting in January & July - No age restrictions
BPharm to MD
inno ative approach
is allowing me
to realise my
Pharmacist from Cairns
Class of 2017
Bacteria, beer and bread
Human gut bacteria that feast on the
yeast contained in fermented foods like
bread and beer are providing clues to
new treatments for people suffering
from bowel diseases.
University of Melbourne researchers
collaborating with scientists from
the UK, USA Canada and Belgium
have unravelled the process healthy
gut bacteria use to degrade complex
carbohydrates in the wall of yeast cells
contained in fermented foods.
Publishing their findings in Nature, the
international research team said the
discovery of this process could accelerate
the development of prebiotic medicines
to help people suffering from bowel
problems and autoimmune diseases.
Co-author Professor Spencer Williams,
School of Chemistry School of
Chemistry, University of Melbourne and
Bio 21 said: 'The common gut bacteria
called Bacteroides thetaiotaomicron can
process the carbohydrates that we can't,
we now know the mechanism of how it
breakdowns the yeast cells."
'This bacteria in turn use the
energy released from the yeast cell
components, called mannans, to
produce important molecules that
nourish the cells that line our gut
wall, and provide immune signals that
establish a healthy immune response.'
The research has potential in developing
sophisticated prebiotics that target the
growth of specific beneficial bacteria
that may assist in fighting off yeast
infections, reactions to fermented foods,
and in autoimmune diseases such as
'Yeast mannans appear to be a
very specific food for this particular
bacterium and thus may have health
promoting effects on our microbiome,
the varied community of bacteria
within us, by specifically stimulating
the growth of beneficial bacteria like
Bacteroides thetaiotaomicron,' Professor
Links Archive Australian Pharmacist January 2015 Australian Pharmacist March 2015 Navigation Previous Page Next Page